{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T10:10:18Z","timestamp":1682331018969},"reference-count":43,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The ability of a Lyme borreliosis vaccine to induce and maintain sustained levels of borreliacidal antibody is necessary for prolonged protection against infection with<jats:italic>Borrelia burgdorferi<\/jats:italic>. Vaccination against infection with<jats:italic>B. burgdorferi<\/jats:italic>could be improved by determining the mechanism(s) that influences the production of protective borreliacidal antibody. Borreliacidal antibody was inhibited in cultures of lymph node cells obtained from C3H\/HeJ mice vaccinated with formalin-inactivated<jats:italic>B. burgdorferi<\/jats:italic>and cultured with macrophages and<jats:italic>B. burgdorferi<\/jats:italic>and treated with recombinant gamma interferon (rIFN-\u03b3). The suppression of production of outer surface protein A (OspA) borreliacidal antibody by rIFN-\u03b3 was not affected by the time of treatment. In addition, treatment with rIFN-\u03b3 inhibited the production of other anti-<jats:italic>B. burgdorferi<\/jats:italic>antibodies. By contrast, treatment of cultures of immune lymph node cells with anti-IFN-\u03b3 marginally increased the production of borreliacidal antibody and enhanced the production of other antibodies directed against<jats:italic>B. burgdorferi<\/jats:italic>. These results show that IFN-\u03b3 does not play a major role in the production of anti-OspA borreliacidal antibody. Additional studies are needed to determine which cytokine(s) will enhance production of borreliacidal antibody.<\/jats:p>","DOI":"10.1128\/cdli.9.5.1095-1101.2002","type":"journal-article","created":{"date-parts":[[2002,8,30]],"date-time":"2002-08-30T18:44:29Z","timestamp":1030733069000},"page":"1095-1101","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["Gamma Interferon Inhibits Production of Anti-OspA Borreliacidal Antibody In Vitro"],"prefix":"10.1128","volume":"9","author":[{"given":"Erik L.","family":"Munson","sequence":"first","affiliation":[{"name":"Wisconsin State Laboratory of Hygiene"},{"name":"Departments of Medical Microbiology and Immunology"},{"name":"Bacteriology, University of Wisconsin, Madison, Wisconsin 53706"},{"name":"Microbiology Research Laboratory and Department of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian K.","family":"Du Chateau","sequence":"additional","affiliation":[{"name":"Wisconsin State Laboratory of Hygiene"},{"name":"Departments of Medical Microbiology and Immunology"},{"name":"Bacteriology, University of Wisconsin, Madison, Wisconsin 53706"},{"name":"Microbiology Research Laboratory and Department of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jani R.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Wisconsin State Laboratory of Hygiene"},{"name":"Departments of Medical Microbiology and Immunology"},{"name":"Bacteriology, University of Wisconsin, Madison, Wisconsin 53706"},{"name":"Microbiology Research Laboratory and Department of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Callister","sequence":"additional","affiliation":[{"name":"Wisconsin State Laboratory of Hygiene"},{"name":"Departments of Medical Microbiology and Immunology"},{"name":"Bacteriology, University of Wisconsin, Madison, Wisconsin 53706"},{"name":"Microbiology Research Laboratory and Department of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"DeCoster","sequence":"additional","affiliation":[{"name":"Wisconsin State Laboratory of Hygiene"},{"name":"Departments of Medical Microbiology and Immunology"},{"name":"Bacteriology, University of Wisconsin, Madison, Wisconsin 53706"},{"name":"Microbiology Research Laboratory and Department of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald F.","family":"Schell","sequence":"additional","affiliation":[{"name":"Wisconsin State Laboratory of Hygiene"},{"name":"Departments of Medical Microbiology and Immunology"},{"name":"Bacteriology, University of Wisconsin, Madison, Wisconsin 53706"},{"name":"Microbiology Research Laboratory and Department of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.4049\/jimmunol.163.8.4182","volume":"163","year":"1999","unstructured":"Allione, A., P. Bernabei, M. Bosticardo, S. Ariotti, G. Forni, and F. Novelli. 1999. Nitric oxide suppresses human T lymphocyte proliferation through IFN-\u03b3-dependent and IFN-\u03b3-independent induction of apoptosis. J. Immunol.163:4182-4191.","journal-title":"J. Immunol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.11.4929-4937.1994"},{"key":"e_1_3_2_4_2","first-page":"521","volume":"57","year":"1984","unstructured":"Barbour, A. G. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med.57:521-525.","journal-title":"Yale J. Biol. Med."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1699-0463.1995.tb01092.x","volume":"103","year":"1995","unstructured":"Belardelli, F. 1995. Role of interferons and other cytokines in the regulation of the immune response. APMIS103:161-179.","journal-title":"APMIS"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","volume":"15","year":"1997","unstructured":"Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-\u03b3. Annu. Rev. Immunol.15:749-795.","journal-title":"Annu. Rev. Immunol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.28.2.363-365.1990"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/infdis\/170.2.499","volume":"170","year":"1994","unstructured":"Callister, S. M., and R. F. Schell. 1994. Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis. J. Infect. Dis.170:499-500.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.9.1773-1776.1991"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/S0021-9258(19)39703-0","volume":"265","year":"1990","unstructured":"Cofano, F., S. K. Moore, S. Tanaka, N. Yuhki, S. Landolfo, and E. Appella. 1990. Affinity purification peptide analysis and cDNA sequence of the mouse interferon \u03b3 receptor. J. Biol. Chem.265:4064-4071.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/infdis\/149.5.789","volume":"149","year":"1984","unstructured":"Craft, J. E., R. L. Grodzicki, and A. C. Steere. 1984. The antibody response in Lyme disease: evaluation of diagnostic tests. J. Infect. Dis.149:789-795.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.2.658-663.2000"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/infdis\/167.2.392","volume":"167","year":"1993","unstructured":"Dressler, F., J. A. Whalen, B. N. Reinhardt, and A. C. Steere. 1993. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis.167:392-400.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.2237407","volume":"250","year":"1990","unstructured":"Fikrig, E., S. W. Barthold, F. S. Kantor, and R. A. Flavell. 1990. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science250:553-556.","journal-title":"Science"},{"key":"e_1_3_2_15_2","unstructured":"Fitch F. W. D. W. Lancki and T. F. Gajewski. 1993. T-cell-mediated immune regulation; help and suppression p. 741. In W. E. Paul (ed.) Fundamental immunology 3rd ed. Raven Press Ltd. New York N.Y."},{"key":"e_1_3_2_16_2","first-page":"381","volume":"81","year":"1994","unstructured":"Garvy, B. A., and R. L. Riley. 1994. IFN-gamma abrogates IL-7-dependent proliferation in pre-B cells, coinciding with onset of apoptosis. Immunology81:381-388.","journal-title":"Immunology"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/eji.1830230237","volume":"23","year":"1993","unstructured":"Grawunder, U., F. Melchers, and A. Rolink. 1993. Interferon-gamma arrests proliferation and causes apoptosis in stromal cell\/interleukin-7-dependent normal murine pre-B cell lines and clones in vitro, but does not induce differentiation to surface immunoglobulin-positive B cells. Eur. J. Immunol.23:544-551.","journal-title":"Eur. J. Immunol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","year":"1970","unstructured":"Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London).227:680-685.","journal-title":"Nature (London)."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jlb.51.5.507","volume":"51","year":"1992","unstructured":"Le Claire, R. D., M. Basu, D. M. Pinson, M. L. Redick, J. S. Hunt, P. J. Zadovny, J. L. Pace, and S. W. Russell. 1992. Characterization and use of monoclonal and polyclonal antibodies against the mouse interferon-\u03b3 receptor. J. Leukoc. Biol.51:507-516.","journal-title":"J. Leukoc. Biol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.7.2825-2833.1994"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4818-4825.1995"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1084\/jem.172.6.1735","volume":"172","year":"1990","unstructured":"Liu, Y., and C. A. Janeway, Jr. 1990. Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self tolerance. J. Exp. Med.172:1735-1739.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0934-8840(11)80398-1","volume":"279","year":"1993","unstructured":"Moskophidis, M., and B. Luther. 1993. Monoclonal antibodies with in vitro borreliacidal activities define the outer surface proteins A and B of Borrelia burgdorferi. Zentbl. Bakteriol.279:201-213.","journal-title":"Zentbl. Bakteriol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.10.5496-5501.2000"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.152.2.496","volume":"152","year":"1994","unstructured":"Novelli, F., F. Di Pierro, P. Francia di Celle, S. Bertini, P. Affaticati, G. Garotta, and G. Forni. 1994. Environmental signals influencing expression of the IFN-\u03b3 receptor on human T cells control whether IFN-\u03b3 promotes proliferation or apoptosis. J. Immunol.152:496-504.","journal-title":"J. Immunol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/infdis\/174.4.739","volume":"174","year":"1996","unstructured":"Padilla, M. L., S. M. Callister, R. F. Schell, G. L. Bryant, D. A. Jobe, S. D. Lovrich, B. K. Du Chateau, and J. R. Jensen. 1996. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine. J. Infect. Dis.174:739-746.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1365-3083.1998.00435.x","volume":"48","year":"1998","unstructured":"Paludan, S. R. 1998. Interleukin-4 and interferon-\u03b3: the quintessence of a mutual antagonistic relationship. Scand. J. Immunol.48:459-468.","journal-title":"Scand. J. Immunol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.iy.05.040187.002241","volume":"5","year":"1987","unstructured":"Paul, W. E., and J. Ohara. 1987. B-cell stimulating factor-1\/interleukin 4. Annu. Rev. Immunol.5:429-459.","journal-title":"Annu. Rev. Immunol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.5.1920-1926.1994"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1086\/515382","volume":"178","year":"1998","unstructured":"Rousselle, J. C., S. M. Callister, R. F. Schell, S. D. Lovrich, D. A. Jobe, J. A. Marks, and C. A. Wieneke. 1998. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi. J. Infect. Dis.178:733-741.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1574-695X.1993.tb00383.x","volume":"7","year":"1993","unstructured":"Sambri, V., S. Armati, and R. Cevinini. 1993. Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in presence of complement. FEMS Immunol. Med. Microbiol.7:67-72.","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.10.3815-3818.1991"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.6.1916-1921.1991"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.10.4523-4526.1993"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM199807233390402","volume":"339","year":"1998","unstructured":"Sigal, L. H., J. M. Zahradnik, P. Lavin, S. J. Patella, G. Bryant, R. Haselby, E. Hilton, M. Kunkel, D. Adler-Klein, T. Doherty, J. Evans, and S. Malawista. 1998. A vaccine consisting of recombinant Borrelia burgdorferi outer surface protein A to prevent Lyme disease. N. Engl. J. Med.339:216-222.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/infdis\/164.1.123","volume":"164","year":"1991","unstructured":"Simon, M. M., U. E. Schaible, M. D. Kramer, C. Eckershorn, C. Museteanu, H. K. Muller-Hermelink, and R. Wallich. 1991. Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochaetal infection in mice. J. Infect. Dis.164:123-132.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_37_2","unstructured":"Snapper C. M. and F. D. Finkelman. 1993. Immunoglobulin class switching p. 837. In W. E. Paul (ed.) Fundamental immunology 3rd ed. Raven Press Ltd. New York N.Y."},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM198303313081301","volume":"308","year":"1983","unstructured":"Steere, A. C., R. L. Grodzicki, A. N. Kornblatt, J. E. Craft, A. G. Barbour, W. Burgdorfer, G. P. Schmid, E. Johnson, and S. E. Malawista. 1983. The spirochetal etiology of Lyme disease. N. Engl. J. Med.308:733-740.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","volume":"339","year":"1998","unstructured":"Steere, A. C., V. K. Sikand, F. Meurice, D. L. Parenti, E. Fikrig, R. T. Schoen, J. Nowakowski, C. H. Schmid, S. Laukamp, C. Buscarino, D. S. Krause, et al. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N. Engl. J. Med.339:209-215.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.10.2745-2751.1995"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.4049\/jimmunol.162.11.6317","volume":"162","year":"1999","unstructured":"Su, L., and M. David. 1999. Inhibition of B cell receptor-mediated apoptosis by IFN. J. Immunol.162:6317-6321.","journal-title":"J. Immunol."},{"key":"e_1_3_2_42_2","unstructured":"Triola M. F. 1992. Elementary statistics 5th ed. p. 544-577. Addison-Wesley Boston Mass."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1086\/514779","volume":"28","year":"1999","unstructured":"Van Hoecke, C., E. Lebacq, J. Beran, and D. Parenti. 1999. Alternative vaccination schedules (0, 1, and 6 months versus 0, 1, and 12 months) for a recombinant OspA Lyme disease vaccine. Clin. Infect. Dis.28:1260-1264.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1126\/science.149.3681.310","volume":"149","year":"1965","unstructured":"Wheelock, E. F. 1965. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science149:310-311.","journal-title":"Science"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.9.5.1095-1101.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.9.5.1095-1101.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T09:56:32Z","timestamp":1682330192000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.9.5.1095-1101.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["10.1128\/CDLI.9.5.1095-1101.2002"],"URL":"https:\/\/doi.org\/10.1128\/cdli.9.5.1095-1101.2002","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]},"assertion":[{"value":"2002-04-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-06-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}